Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial
Por:
Melgosa-Ramos FJ, Vicente-Villa MA, Betlloch Mas I and Santos-Alarcón S
Publicada:
1 abr 2025
Ahead of Print:
1 abr 2025
Resumen:
Filiaciones:
Melgosa-Ramos FJ:
department of dermatology, hospital Lluís Alcanyís, Xátiva, Valencia, Spain
Vicente-Villa MA:
Department of Dermatology, Hospital Sant Joan de Déu, Barcelona, Spain
Betlloch Mas I:
department of dermatology, university General hospital, Alicante, Spain
Santos-Alarcón S:
department of dermatology, hospital Virgen de los Lirios, Alcoy, Alicante, Spain
gold
|